Gut bacterial adhesion mechanism revealed as target for novel colorectal cancer therapies

Fusobacterium nucleatum (F. nucleatum) is an anaerobic bacterium notably enriched in the gut microbiota of colorectal cancer (CRC) patients and may play a role in CRC both by colonizing tumor cells and suppressing immune mechanisms. Understanding how this bacterium adheres to cancer cells could provide key targets for developing novel antitumor therapies.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup